Literature DB >> 27151123

Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.

Rafael Stern1, Stephanie Hametner2, Al-Zoairy Ramona3, Stephan Moser4, Asia Karpi4, Hermann Laferl5, Rudolf E Stauber6, Heinz M Zoller3, Andreas Maieron2, Wolfgang Vogel3, Ivo Graziadei7, Michael Gschwantler4, Karin Kozbial1, Clarissa Freissmuth1, Harald Hofer1, Peter Ferenci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27151123     DOI： 10.1038/ajg.2016.39

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.

Authors:  Yao-Chun Hsu; Jaw-Town Lin; Hsiu J Ho; Yu-Hsi Kao; Yen-Tsung Huang; Nai-Wan Hsiao; Ming-Shiang Wu; Yi-Ya Liu; Chun-Ying Wu
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 2.  HCV targeting of patients with cirrhosis.

Authors:  Peter Ferenci; Karin Kozbial; Mattias Mandorfer; Harald Hofer
Journal:  J Hepatol       Date:  2015-06-19       Impact factor: 25.083

3.  Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older.

Authors:  Sammy Saab; Sarah H Park; Masashi Mizokami; Masao Omata; Alessandra Mangia; Ed Eggleton; Yanni Zhu; Steven J Knox; Phil Pang; Mani Subramanian; Kris Kowdley; Nezam H Afdhal
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

4.  Fried phenotype of frailty: cross-sectional comparison of three frailty stages on various health domains.

Authors:  Linda P M Op het Veld; Erik van Rossum; Gertrudis I J M Kempen; Henrica C W de Vet; KlaasJan Hajema; Anna J H M Beurskens
Journal:  BMC Geriatr       Date:  2015-07-09       Impact factor: 3.921
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.